Immunitybio Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Immunitybio Inc inventory turnover ratio, the Immunitybio Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.43 in the second quarter 2026, a new company high. Average inventory processing period, for the Immunitybio Inc in Jun 30 2026 quarter, has decreased to 849 days, compare to 1460 days, in the Mar 31 2026 quarter.

Within Healthcare sector 354 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1942, from total ranking in the first quarter 2026 at 2117.

IBRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Immunitybio Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IBRX Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-70.78 %	-93.52 %	-89 %	242.34 %	266.65 %
Y / Y Cost of Sales Growth	119.12 %	310.34 %	-	-	-
Inventory Turnover Ratio (TTM)	0.43	0.25	0.13	0.05	0.03
IBRX's Total Ranking	# 1942	# 2117	# 2049	# 2061	# 2078
Average inventory processing period	842	1447	2750	7393	11907
Seq. Inventory Growth	254.66 %	-39.89 %	-86.42 %	0.95 %	-21.36 %
Seq. Cost of Sales Growth	25.21 %	-37.7 %	115.82 %	30.15 %	134.48 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 26
Healthcare Sector	# 355
Overall Market	# 1942

Inventory Turnover Ratio Statistics
High	Average	Low
0.43	0.15	0.01
(Jun 30 2026)		(Mar 31 2025)

IBRX Company Profile >> Back to IBRX Efficiency Comparisons >> Compare IBRX Inventory Turnover Ratio to its Competitors

Financial Statements
Immunitybio Inc 's Inventories	$ 2 Millions	Visit IBRX's Balance sheet
Immunitybio Inc 's Cost of Revenues TTM	$ 1 Millions	Visit IBRX's Income Statement
What are IBRX's Sales?		Visit IBRX's Sales by Segment

Other Inventory Turnover Ratios
Immunitybio Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IBRX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IBRX's Competitors
Inventory Turnover Ratio for IBRX's Suppliers
Inventory Turnover Ratio for IBRX's Customers

You may also want to know
IBRX's Sales Growth Rates	IBRX's Pe Price to earnings ratio	IBRX's Receivables Turnover Ratio	IBRX's Stock Quote
IBRX's Net Income Growth Rates	IBRX's Ps Price to Sales ratio	IBRX's Sales per Employee	IBRX's Asset Turnover Ratio
IBRX's Net Margin	IBRX's Pb Price to Book ratio	IBRX's Financial Strength Ratios	IBRX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Bausch and Lomb Corp	1.54	$ 1,523.000 Millions	$ 989 Millions
Staar Surgical Co	1.53	$ 79.388 Millions	$ 52 Millions
Abeona Therapeutics Inc	1.51	$ 8.405 Millions	$ 6 Millions
Axogen inc	1.45	$ 63.909 Millions	$ 44 Millions
Cv Sciences Inc	1.45	$ 5.804 Millions	$ 4 Millions
Nuwellis Inc	1.43	$ 2.732 Millions	$ 2 Millions
Cormedix Inc	1.42	$ 45.432 Millions	$ 32 Millions
Cumberland Pharmaceuticals Inc	1.41	$ 5.164 Millions	$ 4 Millions
Standard Biotools Inc	1.41	$ 28.569 Millions	$ 20 Millions
Biocorrx Inc	1.40	$ 0.170 Millions	$ 0 Millions
Lensar Inc	1.38	$ 31.126 Millions	$ 23 Millions
Alphatec Holdings Inc	1.32	$ 237.415 Millions	$ 179 Millions
Tenet Healthcare Corp	1.32	$ 453.000 Millions	$ 344 Millions
Xtant Medical Holdings Inc	1.28	$ 43.701 Millions	$ 34 Millions
Edwards Lifesciences Corporation	1.28	$ 1,443.400 Millions	$ 1,129 Millions
Globus Medical Inc	1.27	$ 989.145 Millions	$ 779 Millions
Karyopharm Therapeutics Inc	1.27	$ 4.942 Millions	$ 4 Millions
Clene Inc	1.25	$ 0.059 Millions	$ 0 Millions
Kyntra Bio Inc	1.24	$ 4.444 Millions	$ 4 Millions
Pulmonx Corporation	1.24	$ 20.014 Millions	$ 16 Millions
Biolife Solutions Inc	1.24	$ 39.035 Millions	$ 32 Millions
Stereotaxis Inc	1.23	$ 13.184 Millions	$ 11 Millions
60 Degrees Pharmaceuticals Inc	1.20	$ 0.895 Millions	$ 1 Millions
Bridgebio Pharma Inc	1.16	$ 39.655 Millions	$ 34 Millions
Neuropace Inc	1.14	$ 19.920 Millions	$ 17 Millions
Amarin Corp Plcuk	1.13	$ 108.346 Millions	$ 96 Millions
Brightspring Health Services Inc	1.13	$ 728.559 Millions	$ 647 Millions
Treace Medical Concepts Inc	1.10	$ 42.186 Millions	$ 38 Millions
Corcept Therapeutics Inc	1.10	$ 14.085 Millions	$ 13 Millions
Bio Green Med Solution Inc	1.07	$ 1.244 Millions	$ 1 Millions

Date modified: 2026-08-30T21:40:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.